We came across a bullish thesis on Maze Therapeutics, Inc. on deep market scan subreddit by retroviber. In this article, we will summarize the bulls’ thesis on MAZE. Maze Therapeutics, Inc.'s share was trading at $23.25 as of September 15th. MAZE’s forward P/E was 8.53 according to Yahoo Finance.
[caption id="attachment_574771" align="aligncenter" width="750"]Maze Therapeutics (NASDAQ: MAZE) is showing a compelling move in the small-cap biotech space, driven by a rare combination of premium financing, positive clinical data, and...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.